v3.24.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income (loss) $ (18,875,367) $ (27,883,287)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 4,983,480 478,020
Noncash lease expense 98,536 95,098
Stock compensation 1,095,705 1,098,331
Stock option expense 1,843,731 16,571,978
Accrued investment income (159,692) (392,412)
Accrued recovery of legal fees   (55,364)
Impairment loss on digital assets 965,967 547,200
Impairment loss on mining machine deposits 36,691 3,150,000
Impairment loss on hosting deposits 184,236 1,790,712
Impairment loss on Symbiont assets 750,678  
Unrealized loss (gain) on marketable securities (13,570) 56,830
Unrealized loss (gain) on investment and equity securities 9,771,050 (4,423,985)
Loss on disposal of fixed assets 9,389 38,054
Realized loss (gain) on securities (4,420) 349,920
Realized gain on convertible note receivable   (287,778)
Realized gain on sale of digital assets (2,072,425) (20,254)
Proceeds from securities 744,036 2,565,893
Convertible debt and interest converted into marketable securities   844,882
Investments in marketable securities (739,616) (844,882)
Reversal of allowance loss on debt security (1,052,542) 1,052,542
Change in operating assets and liabilities:    
Prepaid expenses and other assets 189,407 651,472
Hosting deposits (36,691) (3,202,764)
Repayments to related party (52,643) (45,732)
Accounts payable and accrued expenses 177,478 393,260
Mining of digital assets (12,289,131) (945,560)
Proceeds from sale of digital assets 10,874,701  
Lease liability payments (95,948) (98,569)
Income taxes receivable 262,279 (293,466)
Deferred taxes and taxes payable   (326,178)
Net cash used in operating activities (3,404,681) (9,136,039)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capital expenditures (1,625,284) (15,382)
Investment in notes receivable - Seastar Medical Holding Corporation (125,000) (3,753,090)
Collection of notes receivable 2,651,943  
Investment in digital assets (35,157) (988,343)
Proceeds from sale of purchased digital assets 27,815 518,931
Financing activities for Symbiont asset acquisition (402,361)  
Symbiont asset sale 1,800,000  
Deposits for mining equipment   (14,649,614)
Net cash from (used in) investing activities 2,299,537 (18,886,107)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Loan principal and insurance financing repayments (624,481) (299,033)
Issue costs from the issuance of common stock (106,550)  
Net cash used in financing activities (731,031) (299,033)
NET DECREASE IN CASH (1,836,175) (28,321,179)
CASH - BEGINNING OF PERIOD 4,238,006 32,559,185
CASH - END OF PERIOD 2,401,831 4,238,006
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES    
Insurance financing 716,292 660,120
ROU assets and operating lease obligation recognized 21,887 300,787
Reclassification of mining equipment deposit to fixed assets, net 1,177,226 26,961,095
Capital expenditures in accrued liabilities 1,035,374 718,416
Reclassification of Reverse stock split 10,859 0
SUPPLEMENTAL DISCLOSURES OF CASHFLOW INFORMATION    
Cash paid for taxes   2,057,710
Original Product [Member]    
CASH FLOWS FROM INVESTING ACTIVITIES:    
Net collections of finance receivables (6,428) 13,993
Special Product [Member]    
CASH FLOWS FROM INVESTING ACTIVITIES:    
Net collections of finance receivables $ 14,009 $ (12,602)

Source

HTML PDF
ZIP